Literature DB >> 6423795

Characterization of aluminum hydroxide for use as an adjuvant in parenteral vaccines.

S L Hem, J L White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6423795

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN： 0279-7976


× No keyword cloud information.
  6 in total

1.  The importance of surface charge in the optimization of antigen-adjuvant interactions.

Authors:  P M Callahan; A L Shorter; S L Hem
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes.

Authors:  S Cohen; H Bernstein; C Hewes; M Chow; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Desorption of porcine parvovirus from aluminum hydroxide adjuvant with subsequent viral immunoassay or hemagglutination assay.

Authors:  J Katz
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

4.  Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

Authors:  R P Weissburg; P W Berman; J L Cleland; D Eastman; F Farina; S Frie; A Lim; J Mordenti; T T Nguyen; M R Peterson
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

5.  Disparate adjuvant properties among three formulations of "alum".

Authors:  Derek W Cain; Sergio E Sanders; Michael M Cunningham; Garnett Kelsoe
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

6.  Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.

Authors:  Amber L Clausi; Andrea Morin; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.